Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal Anti-PHB Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein of human PHB |
TA349430 is a possible alternative to TA322982.
Rabbit polyclonal IRF-3 (Ser385) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IRF-3 around the phosphorylation site of serine 385 (G-A-SP-S-L). |
| Modifications | Phospho-specific |
Rabbit anti-STAT3 (Phospho-Tyr705) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT3 around the phosphorylation site of tyrosine 705 (A-P-YP-L-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal GR (Ab-211) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GR around the phosphorylation site of serine 211 (N-E-S-P-W). |
Rabbit polyclonal antibody to MCM7 (minichromosome maintenance complex component 7)
| Applications | Assay, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 190 and 481 of MCM7 (Uniprot ID#P33993) |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Rabbit anti-NFKB2 Polyclonal Antibody
| Applications | ICC/IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide of human NFKB2 |
Rabbit Polyclonal GATA3 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | GATA3 antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human GATA3. The immunogen is located within amino acids 340 - 390 of GATA3. |
Rabbit anti-STAT5A (Phospho-Tyr694) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT5A around the phosphorylation site of tyrosine 694 (D-G-YP-V-K). |
| Modifications | Phospho-specific |
Rabbit Polyclonal CREB (Ser133) Antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against a synthesized A synthesized peptide derived from human CREB around the phosphorylation site of Sersine 133. |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against SQSTM1
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This SQSTM1 (p62) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 317-346 amino acids from the C-terminal region of human SQSTM1 (p62). |
Rabbit Polyclonal DEDAF Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | DEDAF antibody was raised against a synthetic peptide corresponding to amino acids 215 to 228 of human DEDAF. The sequence is identical to that of mouse origin. |
Active filters
Reactivities
- Rat
Applications
- IHC
Clonalities
- Polyclonal
Conjugates
- Unconjugated
Families
- Transcription Factors
Availabilities
- In Stock
Filter by
Category
Target Symbol
- ATF2 (5)
- NR3C1 (5)
- HDAC1 (4)
- JUN (4)
- KAT5 (4)
- STAT5B (4)
- AHR (3)
- CREB1 (3)
- FOS (3)
- HDAC2 (3)
- HNF1B (3)
- JUND (3)
- NFKB2 (3)
- PTMA (3)
- RAB25 (3)
- RAN (3)
- STAT1 (3)
- STAT3 (3)
- ACAD8 (2)
- APEX1 (2)
- CBX8 (2)
- CCNC (2)
- CCNE1 (2)
- CEBPG (2)
- CNNM3 (2)
- CTNNB1 (2)
- DNMT1 (2)
- DTX1 (2)
- ENO1 (2)
- EP300 (2)
- ESR1 (2)
- FOXD2 (2)
- FOXO3 (2)
- FOXR2 (2)
- GATA6 (2)
- HDAC4 (2)
- HMGA1 (2)
- HMGB1 (2)
- HMGN5 (2)
- ID2 (2)
- JUNB (2)
- MCM3 (2)
- MCM7 (2)
- NFKBIE (2)
- PARD6A (2)
- PAWR (2)
- PAX8 (2)
- PDX1 (2)
- PIAS3 (2)
- POU2F1 (2)
- POU5F1 (2)
- PRDX3 (2)
- PTTG1 (2)
- RAB8A (2)
- RARA (2)
- RELA (2)
- SMAD1 (2)
- SMAD5 (2)
- SP1 (2)
- SREBF2 (2)
- SRF (2)
- SSB (2)
- SUMO1 (2)
- TCF3 (2)
- TERF1 (2)
- TERF2 (2)
- TNF (2)
- TONSL (2)
- TP73 (2)
- TRIM32 (2)
- TSC22D1 (2)
- XRCC6 (2)
- YBX1 (2)
- ADNP (1)
- AEBP1 (1)
- AIP (1)
- ARNT (1)
- ASCC2 (1)
- ASCL1 (1)
- ATF4 (1)
- ATF6 (1)
- BTG1 (1)
- CALR (1)
- CBFB (1)
- CBX4 (1)
- CBY1 (1)
- CCNT2 (1)
- CDC5L (1)
- CEBPB (1)
- CEBPD (1)
- CERS2 (1)
- CLOCK (1)
- CNOT2 (1)
- COPS5 (1)
- CRABP2 (1)
- CRK (1)
- DEAF1 (1)
- DLX3 (1)
- DLX5 (1)
- DNM2 (1)
Antibody Hosts
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (62)
- MAPK signaling pathway (36)
- Cell cycle (25)
- Chronic myeloid leukemia (21)
- Jak-STAT signaling pathway (19)
- Toll-like receptor signaling pathway (19)
- Wnt signaling pathway (19)
- Acute myeloid leukemia (18)
- Chemokine signaling pathway (18)
- Prostate cancer (18)
- T cell receptor signaling pathway (18)
- TGF-beta signaling pathway (18)
- B cell receptor signaling pathway (16)
- Huntington's disease (15)
- Neurotrophin signaling pathway (15)
- Adipocytokine signaling pathway (14)
- ErbB signaling pathway (13)
- Pancreatic cancer (13)
- Colorectal cancer (12)
- Small cell lung cancer (12)
- Notch signaling pathway (11)
- Renal cell carcinoma (11)
- Metabolic pathways (10)
- Ubiquitin mediated proteolysis (9)
- DNA replication (8)
- Epithelial cell signaling in Helicobacter pylori infection (8)
- Focal adhesion (8)
- Melanogenesis (8)
- RIG-I-like receptor signaling pathway (8)
- Thyroid cancer (8)
- Adherens junction (7)
- Apoptosis (7)
- Endocytosis (7)
- Endometrial cancer (7)
- GnRH signaling pathway (7)
- p53 signaling pathway (7)
- Cytosolic DNA-sensing pathway (6)
- NOD-like receptor signaling pathway (6)
- Neuroactive ligand-receptor interaction (6)
- Base excision repair (5)
- Maturity onset diabetes of the young (5)
- Natural killer cell mediated cytotoxicity (5)
- Oocyte meiosis (5)
- Tight junction (5)
- Alzheimer's disease (4)
- Amyotrophic lateral sclerosis (ALS) (4)
- Antigen processing and presentation (4)
- Basal cell carcinoma (4)
- Non-small cell lung cancer (4)
- PPAR signaling pathway (4)
- Systemic lupus erythematosus (4)
- Type II diabetes mellitus (4)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (3)
- Axon guidance (3)
- Bladder cancer (3)
- Cysteine and methionine metabolism (3)
- Cytokine-cytokine receptor interaction (3)
- Fc epsilon RI signaling pathway (3)
- Insulin signaling pathway (3)
- Long-term potentiation (3)
- RNA degradation (3)
- VEGF signaling pathway (3)
- Allograft rejection (2)
- Asthma (2)
- Basal transcription factors (2)
- Dilated cardiomyopathy (2)
- Fc gamma R-mediated phagocytosis (2)
- Glioma (2)
- Glycolysis / Gluconeogenesis (2)
- Graft-versus-host disease (2)
- Hematopoietic cell lineage (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Leukocyte transendothelial migration (2)
- Melanoma (2)
- Non-homologous end-joining (2)
- Pathogenic Escherichia coli infection (2)
- Type I diabetes mellitus (2)
- Valine (2)
- leucine and isoleucine degradation (2)
- Biosynthesis of unsaturated fatty acids (1)
- Calcium signaling pathway (1)
- Circadian rhythm - mammal (1)
- Glycerolipid metabolism (1)
- Glycine (1)
- Glyoxylate and dicarboxylate metabolism (1)
- Hedgehog signaling pathway (1)
- Homologous recombination (1)
- Long-term depression (1)
- Primary immunodeficiency (1)
- Prion diseases (1)
- Purine metabolism (1)
- Pyrimidine metabolism (1)
- Regulation of actin cytoskeleton (1)
- Ribosome (1)
- Spliceosome (1)
- Viral myocarditis (1)
- mTOR signaling pathway (1)
- serine and threonine metabolism (1)